- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Nymalize
Synonyms :
nimodipine
Class :
Calcium channel blockers and antihypertensives
Dosage Forms & Strengths
Capsule, Oral:
30 mg
Solution, Oral:
30 mg/10ml
60 mg/20ml
6mg/ml (5ml, 10 ml, 237ml)
Note: Use of the oral solution is discontinued in the United States.
Refer to adult dosing
may increase the hypotensive effect of alpha1-blockers
CYP3A4 inducers decrease the concentration of nimodipine in the serum
CYP3A4 inducers decrease the concentration of nimodipine in the serum
CYP3A strong enhancers of the small intestine may reduce the bioavailability of nimodipine
May enhance the hyperkalemic effect when combined with Calcium Channel Blockers
may diminish the serum concentration when combined with nimodipine
may diminish the serum concentration when combined with nimodipine
may diminish the serum concentration when combined with nimodipine
may diminish the serum concentration when combined with nimodipine
may diminish the serum concentration when combined with nimodipine
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may enhance the concentration of serum when combined with nimodipine
may enhance the concentration of serum when combined with nimodipine
may enhance the concentration of serum when combined with nimodipine
may enhance the concentration of serum when combined with nimodipine
may enhance the concentration of serum when combined with nimodipine
nimodipine: they may diminish the serum concentration of CYP3A4 Inducers
it may diminish the therapeutic efficacy when combined with castor oil
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
the effect of nimodipine is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
CYP3A4 inhibitors increase the concentration of nimodipine in serum
CYP3A4 inducers decrease the concentration of nimodipine in serum
May enhances the effects of the other by pharmacodynamic synergism
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may enhance the serum concentration when combined with calcium channel blockers
may have an increased orthostatic hypotensive effect when combined with calcium channel blockers
may enhance the serum concentration of CYP3A4 inhibitors
may increase the hypotensive effect of Inhalational Anaesthetics
may enhance the serum concentration of CYP3A4 Inhibitors
may enhance the serum concentration of CYP3A4 Inhibitors
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
it increases the toxicity of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
Frequency defined:
1% to 10%
Reduced blood pressure
Bradycardia
Headache
Nausea
<1% Postmarketing
Anemia
Dizziness
Edema
Flushing
Increased serum ALT
Increased serum glucose
Pruritus
Psoriasis
Vomiting
Wheezing
Pregnancy consideration: Nimodipine is used for the management of subarachnoid hemorrhage in pregnant patients. It can cause fetal-maternal hypotension.
Lactation: nimodipine can be excreted in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: Nimodipine
Pronounced: nimodipine
Why do we use nimodipine?
Nimodipine is used for the treatment of subarachnoid hemorrhage and may be prescribed for other reasons by a doctor.